Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the reciprocal t(9;22) translocation, the Philadelphia chromosome, leading to the formation of the oncogenic BCR::ABL1 fusion gene with autonomous tyrosine kinase activity [1, 2]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.